Ambivalence and the biopolitics of HIV pre-exposure prophylaxis (PrEP) implementation

被引:12
|
作者
Gaspar, Mark [1 ]
Salway, Travis [2 ]
Grace, Daniel [3 ]
机构
[1] Univ Toronto, Dalla Lana Sch Publ Hlth, 155 Coll St,Room 510, Toronto, ON M5T 3M7, Canada
[2] Simon Fraser Univ, Fac Hlth Sci, Blusson Hall,Room 11300,8888 Univ Dr, Burnaby, BC V5A 1S6, Canada
[3] Univ Toronto, Dalla Lana Sch Publ Hlth, 155 Coll St,Room 556, Toronto, ON M5T 3M7, Canada
基金
加拿大健康研究院;
关键词
Ambivalence; Biopolitics; HIV; PrEP; Gay; bisexual; queer and other men who have sex with men; Epistemology; PREVENTION; RETHINKING; HEALTH; AIDS; MEN; SEX;
D O I
10.1057/s41285-020-00154-w
中图分类号
R318 [生物医学工程]; C [社会科学总论];
学科分类号
03 ; 0303 ; 0831 ;
摘要
Ambivalence, the vacillation between conflicting feelings and thoughts, is a key characteristic of scientific knowledge production and emergent biomedical technology. Drawing from sociological theory on ambivalence, we have examined three areas of debate surrounding the early implementation of HIV pre-exposure prophylaxis, or PrEP, for gay, bisexual, queer, and other men who have sex with men in Canada, including epistemology and praxis, clinical and epidemiological implications, and sexual politics. These debates are not focused on the science or efficacy of PrEP to prevent HIV, but rather represent contradictory feelings and opinions about the biopolitics of PrEP and health inequities. Emphasizing how scientists and health practitioners may feel conflicted about the biopolitics of novel biomedical technologies opens up opportunities to consider how a scientific field is or is not adequately advancing issues of equity. Scientists ignoring their ambivalence over the state of their research field may be deemed necessary to achieve a specific implementation goal, but this emotion management work can lead to alienation. We argue that recognizing the emotional dimensions of doing HIV research is not a distraction from "real" science, but can instead be a reflexive site to develop pertinent lines of inquiry better suited at addressing health inequities.
引用
收藏
页码:171 / 187
页数:17
相关论文
共 50 条
  • [1] Ambivalence and the biopolitics of HIV pre-exposure prophylaxis (PrEP) implementation
    Mark Gaspar
    Travis Salway
    Daniel Grace
    [J]. Social Theory & Health, 2022, 20 : 171 - 187
  • [2] HIV pre-exposure prophylaxis (PrEP)
    Tumarkin, Ethan
    Siedner, Mark J.
    Bogoch, Isaac I.
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 2019, 364
  • [3] PrEP: pre-exposure prophylaxis for HIV prevention
    Page, Matthew
    Nicholls, Jane
    [J]. TRENDS IN UROLOGY & MENS HEALTH, 2018, 9 (04) : 22 - 24
  • [4] HIV pre-exposure prophylaxis (PrEP); [Pre-expositieprofylaxe tegen hiv (PrEP)]
    Hermanussen R.
    [J]. Huisarts en wetenschap, 2017, 60 (6) : 264 - 267
  • [5] Implementation of a pharmacist-led pre-exposure HIV prophylaxis (PrEP) Clinic
    Miller, Michelle
    Nisly, Nicole
    [J]. PHARMACOTHERAPY, 2017, 37 (12): : E217 - E217
  • [6] Pre-Exposure Prophylaxis (PrEP): NYC Implementation Strategy
    Daskalakis, Demetre
    [J]. AIDS RESEARCH AND HUMAN RETROVIRUSES, 2016, 32 : 28 - 28
  • [7] Pre-exposure HIV prophylaxis (PrEP) background and controversies
    Zalewski, Bartlomiej M.
    Jablonska, Monika
    Mikula, Tomasz
    [J]. HIV & AIDS REVIEW, 2009, 8 (04): : 8 - 10
  • [8] State of the Science - HIV Pre-Exposure Prophylaxis (PrEP)
    Chariyalertsak, S.
    [J]. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2012, 16 : E9 - E10
  • [9] Pre-exposure prophylaxis (PrEP)
    Bradshaw, Helen
    [J]. HIV MEDICINE, 2021, 22 : 47 - 47
  • [10] Preparing for PrEP: Perceptions and Readiness of Canadian Physicians for the Implementation of HIV Pre-Exposure Prophylaxis
    Sharma, Malika
    Wilton, James
    Senn, Heather
    Fowler, Shawn
    Tan, Darrell H. S.
    [J]. PLOS ONE, 2014, 9 (08):